At the news
? BEARISHIMPACT 6/10 8-K filed Jun 10, 2026 at 16:10 ET
IDEAYA Biosciences completed a follow-on public offering on June 10, 2026, selling 7,222,225 shares of common stock and pre-funded warrants to purchase 5,555,576 shares, generating net proceeds of approximately $323.6 million. This is a material dilutive event for a $2.5B market cap company. Stockholders' equity per share is diluted by this issuance, although the ~$323.6M in new cash extends the cash runway for clinical development.
- Sold 7,222,225 shares of common stock at $27.00/share and pre-funded warrants for 5,555,576 shares at $26.9999/warrant.
- Net proceeds of approximately $323.6 million after underwriting discounts and estimated expenses.
- Pre-funded warrants have an exercise price of $0.0001 per share, meaning investors effectively bought common stock exposure at the offering price minus a de minimis exercise price.
- Underwriters' option for 1,666,669 additional shares was exercised in full.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access